Novel frameworks as a source of high-affinity ligands

Current Opinion in Biotechnology

Volumn 12, Issue 4, 2001, Pages 406-410

  Ladner, Robert C ^a   Ley, Arthur C ^a  

^a Dyax Corp   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; DNA; LIGAND; NUCLEIC ACID; PEPTIDE;

AMINO ACID SEQUENCE; DNA PACKAGING; MOLECULAR SIZE; PHAGE DISPLAY; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN DOMAIN; PROTEIN PROCESSING; REVIEW; TECHNIQUE;

EID: 0035423718     PISSN: 09581669     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0958-1669(00)00235-4     Document Type: Review

References (38)

1. Phage display in pharmaceutical biotechnology
2. Natural and designer binding sites made by phage display technology
3. A novel approach for the identification of unique tumor vasculature binding peptides using an E. coli peptide display library
4. Bacterial cell surface display of an enzyme library for selective screening of improved cellulase variants
5. Directed evolution of a stable scaffold for T-cell receptor engineering
6. Ribosome display and affinity maturation: From antibodies to single V-domains and steps towards cancer therapeutics
7. In vitro selection of functional nucleic acids
8. Aptamers as therapeutic and diagnostic agents
9. Adaptive recognition by nucleic acid aptamers
10. Delineation of a linear epitope by multiple peptide synthesis and phage display
11. Binding to protein targets of peptidic leads discovered by phage display: Crystal structures of streptavidin-bound linear and cyclic peptide ligands containing the HPQ sequence
12. Improving SH3 domain ligand selectivity using a non-natural scaffold
13. Collagen mimetics
14. SH3-SPOT: An algorithm to predict preferred ligands to different members of the SH3 gene family
15. The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: Peptoid molecular transporters
16. M13 bacteriophage displaying disulfide-constrained microproteins
17. Peptide exosite inhibitors of factor VIIa as anticoagulants
18. Novel peptides selected to bind vascular endothelial growth factor target the receptor-binding site
19. A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin
20. Lipocalins as a scaffold
21. Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold
22. Anticalins versus antibodies: Made-to- order binding proteins for small molecules
23. Engineering microprotein ligands for large-scale affinity purification
24. Custom affinity ligands from phage display for large-scale purification
25. M and Taq DNA polymerase
26. Binding proteins selected from combinatorial libraries of an α-helical bacterial receptor domain
27. Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling
28. α-Amylase inhibitors selected from a combinatorial library of a cellulose binding domain scaffold
29. Small binding proteins selected from a combinatorial repertoire of knottins displayed on phage
30. Solution structure of the major α-amylase inhibitor of the crop plant amaranth
31. Specific inhibition of insect α-amylase in complex with the amaranth α-amylase inhibitor at 2.0 Å resolution
32. Potent and selective Kunitz domain inhibitors of plasma kallikrein designed by phage display
33. Iterative optimization of high-affinity protease inhibitors using phage display. I. Plasmin
34. Development and application of cytotoxic T-lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands
35. Design and expression of soluble CTLA-4 variable domain as a scaffold for the display of functional polypeptides
36. The lipocalin protein family: Structure and function
37. Symmetry of Fv architecture is conducive to grafting a second antibody binding site in the Fv region
38. Design and application of diabodies, triabodies and tetrabodies for cancer targeting